Overcoming Resistance To Targeted Cancer Drug
9/09/2011
Scientists at Dana-Farber Cancer Institute and colleagues overseas have discovered a pair of backup circuits in cancer cells that enable the cells to dodge the effect of a widely used cancer drug. Jamming those circuits with targeted therapies may heighten or restore the drug's potency, according to a study published in Science Translational Medicine...
Breast Tissue Reconstruction Using Computer-Aided Design
9/09/2011
A technology usually reserved for designing buildings, bridges and aircraft has now been used to aid breast tissue reconstruction in cancer patients. In a study published in IOP Publishing's journal Biofabrication, researchers used computer-aided design (CAD) to create an extremely accurate mould of a breast that was used as a visual aid to surgeons in tissue reconstruction operations...
Effective New Strategy For Treating Aggressive Breast Cancer Revealed By Singapore Scientists
9/08/2011
The 2nd September issue of the journal Molecular Cell has published a discovery that opens the door for the development of more effective treatment strategies for aggressive breast cancers associated with EZH2, an enzyme that promotes the estrogen receptor-negative aggressive breast cancer, which remains unresponsive to current treatment strategies...
Lift Of Ban On Blood Donations For Men Who Have Intercourse With Men Supported By Study, UK
9/08/2011
Bmj.com today published information of a new research, which supports changing the lifetime blood donation ban imposed, on men who have intercourse with men. UK Health Ministers announced the decision on the this morning in a press briefing at the Department of Health (Richmond House, 79 Whitehall, SW1A 2NS from 10am) to which journalists were invited to attend...
The September issue of the journals Clinical Cancer Research and Cancer Research published OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announcement of new data from its Phase II clinical and a pre-clinical study of custirsen (OGX-011/TV-1011), a drug that inhibits the production of clusterin, which is a protein commonly over-produced in cancer cells and a cause of treatment failure...
Zytiga® For Treatment Of Metastatic Castration-Resistant Prostate Cancer, Approved In Europe
9/08/2011
This week, Janssen-Cilag International NV announced that, following an accelerated regulatory review process by the European Medicines Agency (EMA) and after a positive CHMP opinion on the 22 July 2011, marketing authorization for ZYTIGA® (abiraterone acetate), a new, once-daily, oral androgen biosynthesis inhibitor has been approved by the European Commission...
Funded by the National Cancer Institute, investigators with the UCLA Department of Radiation Oncology at UCLA's Jonsson Comprehensive Cancer Center have discovered that the metabolic state of glioma stem cells, which instigate deadly glioblastomas, is considerably different from the metabolic state of brain cancer cells which the glioma stem cells created, a factor which as...
Flaxseed No Help For Hot Flashes During Breast Cancer Or Menopause, Study Finds
9/08/2011
A study by Mayo Clinic physician and North Central Cancer Treatment Group (NCCTG) researcher Sandhya Pruthi, M.D., and colleagues found that flaxseed provided no benefit in easing hot flashes among breast cancer patients and postmenopausal women. The study is in the current online version of the journal Menopause...
Young Women With Early Breast Cancer Have Similar Survival With Breast Conservation, Mastectomy
9/08/2011
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept...
Study Points To Strategy For Overcoming Resistance To Targeted Cancer Drug
9/08/2011
Scientists at Dana-Farber Cancer Institute and colleagues overseas have discovered a pair of backup circuits in cancer cells that enable the cells to dodge the effect of a widely used cancer drug. Jamming those circuits with targeted therapies may heighten or restore the drug's potency, according to a study published in the Sept. 7 issue of Science Translational Medicine...